Stroke research studies
We are recruiting for two studies within stroke:
The overall aim of our research is to find out whether fluoxetine improves recovery if given to stroke survivors who are between 2 and 15 days after the onset of their stroke, and who still have residual problems such as a weak arm, weak leg or language problems. We will also find out whether it helps the stroke survivor overcome weakness, communication difficulties or fatigue. We will do this by performing a large randomised trial in the UK, recruiting approximately 3000 patients. Half the patients will be randomly allocated fluoxetine for 6 months, and the other half will receive a placebo pill. For patients who cannot swallow, we will give the drug or a matching placebo through their feeding tube. Patients will be followed up at 6 months, and then at 12 months, to see whether any benefits persist long-term.
Visual problems can occur in three quarters of stroke survivors and this can have an impact on quality of life. There are 4 main types of visual problem which are: central vision loss, visual field loss, eye movement problems and visual processing problems. This new stroke study is called IVIS – impact of visual impairment after stroke. Patients are given a cognitive screen to complete and are asked to complete a questionnaire. Following this a referral may be made for further assessment if necessary.